Key result
Severe anxiety and depressive symptoms are linked to significantly lower post-MI medication adherence.
Why the study?
There was a need to evaluate the impact of anxiety and depression on medication adherence in post-myocardial infarction patients, as psychological conditions may affect adherence.
Does anxiety and depression reduce medication adherence in patients post-myocardial infarction?
Cross-Sectional (n=300)
Yes
Does anxiety and depression reduce medication adherence in patients post-myocardial infarction?
Anxiety and depression are prevalent post-MI and significantly reduce adherence to secondary prevention medications, underscoring the critical need for psychological screening in cardiac rehabilitation.
May support anxiety/depression screening in post-MI care; hypothesis-generating for whether treatment improves adherence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zubi et al. (2023) conducted a cross-sectional in Post-myocardial infarction (n=300). Anxiety and depression vs. Absence of or lower severity of anxiety and depression was evaluated on Medication adherence measured by the General Medication Adherence Scale (GMAS) (Standardized Beta -0.345 for anxiety and -0.243 for depression, p=<0.001). In post-myocardial infarction patients, increased severity of anxiety and depressive symptoms significantly predicted lower medication adherence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: